Clinical decision-making and myocardial viability: Current perspectives

Internal Medicine Journal

Volumn 35, Issue 2, 2005, Pages 118-125

  Nelson, C ^a   Marwick, T H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Echocardiography; Magnetic resonance imaging; Myocardial infarction; Single photon emission computed tomography; Viable myocardium

Indexed keywords

CONTRAST MEDIUM; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; THALLIUM 201;

AKINESIA; ANGINA PECTORIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOKINESIA; LOW DRUG DOSE; MEDICAL DECISION MAKING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; Q WAVE; REVIEW; SCAR FORMATION;

CELL SURVIVAL; DECISION MAKING; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; RECOVERY OF FUNCTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 14844298689     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00740.x     Document Type: Review

References (70)

1. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633-44.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-21.
3. Frangogiannis NG, Shimoni S, Chang S, Ren G, Dewald O, Gersch C et al. Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol 2002; 39: 1468-74.
4. Cornel JH, Bax JJ, Elhendy A, Maat AP, Kimman GJ, Geleijnse ML et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularisation in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998; 31: 1002-10.
5. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-44.
6. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-8.
7. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-60.
8. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-9.
9. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995; 76: 479-88.
10. Shivalkar B, Flameng W, Szilard M, Pislaru S, Borgers M, Vanhaecke J. Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol 1999; 34: 2126-36.
11. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-23.
12. Pelberg RA, Spotnitz WD, Bin JP, Le E, Goodman NC, Kaul S. Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications. J Am Soc Echocardiogr 2001; 14: 1047-56.
13. Shivalkar B, Maes A, Borgers M, Ausma J, Scheys I, Nuyts J et al. Only hibernating myocardium invariably shows early recovery after coronary revascularisation. Circulation 1996; 94: 308-15.
14. Vanoverschelde J-LJ, Depre C, Gerber BL, Borgers M, Wijns W, Robert A et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000; 85: 1432-9.
15. Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000; 83: 456-61.
16. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-8.
17. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularised patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998; 32: 912-20.
18. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularisation. Am J Cardiol 1992; 69: 854-9.
19. Vanoverschelde JL, D'Hondt AM, Marwick TH, Gerber BL, De Kock M, Dion R et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28: 432-42.
20. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularisation in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 34: 163-9.
21. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-33.
22. Kron IL, Flanagan TL, Blackboulerne LH, Schroeder RA, Nolan SP. Coronary revascularisation rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989; 210: 348-52; discussion 52-4.
23. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999; 33: 750-8.
24. Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002; 40: 869-76.
25. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999; 100: 1464-80.
26. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1159-62.
27. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-70.
28. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32: 921-6.
29. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999; 34: 730-8.
30. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.
31. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 1997; 337: 1569-75.
32. Holmes DR, Davis KB, Mock MB, Fisher LD, Gersh BJ, Killip T 3rd et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the coronary artery surgery study. Circulation 1986; 73: 1254-63.
33. Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomised study of coronary bypass surgery. Circulation 1985; 72: V90-101.
34. O'Rourke RA. Role of myocardial revascularisation in sudden cardiac death. Circulation 1992; 85: 1112-17.
35. Every NR, Fahrenbruch CE, Hallstrom AP, Weaver WD, Cobb LA. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol 1992; 19: 1435-9.
36. Brockes C, Rahn-Schonbeck M, Duru F, Candinas R, Seifen B, Turina M. ICD implantation with and without combined myocardial revascularisation - incidence of ICD therapy and late survival. Thorac Cardiovasc Surg 2002; 50: 333-6.
37. Kron IL, Lerman BB, Haines DE, Flanagan TL, DiMarco JP. Coronary artery bypass grafting in patients with ventricular fibrillation. Ann Thorac Surg 1989; 48: 85-9.
38. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-95.
39. Mitropoulos FA, Elefteriades JA. Myocardial revascularisation as a therapeutic strategy in the patient with advanced ventricular dysfunction. Heart Fail Rev 2001; 6: 163-75.
40. Mele D, Campana M, Sclavo M, Seveso G, Aschieri D, Nesta F et al. Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. Eur J Echocardiogr 2003; 4: 59-67.
41. Sechtem U, Baer FM, Voth E, Theissen P, Schneider CA. Stress functional MRI. Detection of ischemic heart disease and myocardial viability. J Magn Reson Imaging 1999; 10: 667-75.
42. Armstrong WF. 'Hibernating' myocardium: asleep or part dead? J Am Coll Cardiol 1996; 28: 530-5.
43. Auerbach MA, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999; 99: 2921-6.
44. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary: a Report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the society for cardiac angiography and interventions. Circulation 2001; 103: 3019-41.
45. Killip T, Passamani E, Davis K. Coronary artery surgery study (CASS): a randomised trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985; 72: V102-9.
46. Chaitman BR, Ryan TJ, Kronmal RA, Foster ED, Frommer PL, Killip T. Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomised and randomizable patients. J Am Coll Cardiol 1990; 16: 1071-8.
47. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-80.
48. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation 1995; 91: 2325-34.
49. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H et al Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 1995; 91: 2335-44.
50. Myers WO, Gersh BJ, Fisher LD, Mock MB, Holmes DR, Schaff HV et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg 1987; 44: 471-86.
51. Petretta M, Cuocolo A, Nicolai E, Acampa W, Salvatore M, Bonaduce D. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1998; 5: 378-86.
52. Petretta M, Cuocolo A, Bonaduce D, Nicolai E, Vicario ML, Salvatore M. Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging. J Nucl Cardiol 1997; 4: 387-95.
53. Pasquet A, Robert A, D'Hondt A-M, Dion R, Melin JA, Vanoverschelde J-LJ. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999; 100: 141-8.
54. Cleland JG, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S et al. The Heart Failure Revascularisation Trial (HEART): rationale, design and methodology. Eur J Heart Fail 2003; 5: 295-303.
55. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-63.
56. Engblom H, Wagner GS, Setser RM, Selvester RH, Billgren T, Kasper JM et al. Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring. Am Heart J 2003; 146: 359-66.
57. Faletra F, Crivellaro W, Pirelli S, Parodi O, De Chiara F, Cipriani M et al. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior wall myocardial infarction. Am J Cardiol 1995; 76: 1002-6.
58. Cwajg JM, Cwajg E, Nagueh SF, He ZX, Qureshi U, Olmos LI et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000; 35: 1152-61.
59. Sayad DE, Willett DL, Bridges WH, Chwialkowski M, McColl R, Payne J et al. Noninvasive quantitation of left ventricular wall thickening using cine magnetic resonance imaging with myocardial tagging. Am J Cardiol 1995; 76: 985-9.
60. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularisation. J Am Coll Cardiol 1998; 31: 1040-8.
61. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Marin-Neto JA, Arrighi JA et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1992; 20: 161-8.
62. Fieno DS, Kim RJ, Chen E-L, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-91.
63. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001; 104: 1101-7.
64. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-8.
65. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.
66. Nelson C, McCrohon J, Khafagi F, Rose S, Leano R, Marwick TH. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium SPECT: a comparison with contrast enhanced magnetic resonance imaging. J Am Coll Cardiol 2004; 43: 1248-56.
67. Nagueh SF, Mikati I, Weilbaecher D, Reardon MJ, Al-Zaghrini GJ, Cacela D et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 1999; 100: 490-6.
68. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-8.
69. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I et al. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996; 94: 1010-17.
70. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003; 24: 789-800.